Physician profile
Ellen Hagopian
NPI 1982628327
$2,783.49
in general payments reported to CMS, 2019-2025
10 companies · $165 in 2025
The $165 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,813 · 2021: $165 · 2022: $99.67 · 2023: $282 · 2024: $258 · 2025: $165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $705.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $1,750.00 | 2019 | |
| Dilon Technologies, INC. | $420.07 | 2023-2025 | Hemoblast Bellows |
| Biom'Up France Sas | $165.00 | 2021 | |
| Intera Oncology, INC | $113.14 | 2024 | Intera |
| Abbvie INC. | $99.67 | 2022 | |
| Medical Device Business Services, INC. | $87.31 | 2019-2025 | Vistaseal |
| Davol INC. | $68.93 | 2023 | Arista Ah Flexitip |
| Astrazeneca Pharmaceuticals LP | $46.35 | 2023 | Andexxa |
| Heron Therapeutics, INC. | $33.02 | 2023 | Zynrelef |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Hagopian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.